Dyne Therapeutics, Inc.DYNNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank64
3Y CAGR+35.3%
5Y CAGR+40.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+35.3%/yr
vs +171.8%/yr prior
5Y CAGR
+40.5%/yr
Recent deceleration
Acceleration
-136.5pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
5.5x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $69.85M | +11.8% |
| 2024 | $62.48M | +99.0% |
| 2023 | $31.40M | +11.3% |
| 2022 | $28.20M | -1.8% |
| 2021 | $28.72M | +125.3% |
| 2020 | $12.75M | +357.5% |
| 2019 | $2.79M | +438.9% |
| 2018 | $517000.00 | -99.7% |
| 2017 | $189.00M | +17.4% |
| 2016 | $161.00M | - |